PSORIASIS ETIOPATOGENESIS AND PHARMACOTHERAPY - PowerPoint PPT Presentation

1 / 47
About This Presentation
Title:

PSORIASIS ETIOPATOGENESIS AND PHARMACOTHERAPY

Description:

PSORIASIS ETIOPATOGENESIS AND PHARMACOTHERAPY BY VINEETHA B MENON PHARM.D (PB) FIRST YEAR JSS COLLEGE OF PHARMACY, MYSORE * * 4. COAL TAR Used in combination with ... – PowerPoint PPT presentation

Number of Views:336
Avg rating:3.0/5.0
Slides: 48
Provided by: DIX46
Category:

less

Transcript and Presenter's Notes

Title: PSORIASIS ETIOPATOGENESIS AND PHARMACOTHERAPY


1
PSORIASIS ETIOPATOGENESIS AND PHARMACOTHERAPY
  • BY
  • VINEETHA B MENON
  • PHARM.D (PB)
  • FIRST YEAR
  • JSS COLLEGE OF PHARMACY, MYSORE

2
CONTENTS
  • INTRODUCTION
  • EPIDEMIOLOGY
  • AETIOLOGY
  • PATHOGENESIS
  • DIAGNOSIS
  • CLINICAL FEATURES
  • TREATMENT

3
INTRODUCTION
  • Psoriasis is a chronic inflammatory condition
    that may affect the skin and joints

4
  • EPIDEMIOLOGY

5
EPIDEMIOLOGY
  • Psoriasis affects both sexes equally
  • Can occur at any age, although it most commonly
    appears for the first time between the ages of 15
    and 25 years

6
  • AETIOLOGY

7
AETIOLOGY
  • Genetic predisposition DR7 CW6
  • Non-hereditary factors
  • Infection
  • Koebner phenomenon
  • Lithium, chloroquine, ß-blockers
  • Stress
  • Smoking Alcohol

8
  • PATHOGENESIS

9
PATHOGENESIS
  • Many changes occur in the skin
  • Epidermis Acanthosis, Parakeratosis
  • Dermis capillaries are dilated, twisted, closer
    to the surface of the skin

10
  • Large number of inflammatory cells are present in
    all layers of the skin- granulocytes are
    predominant and form micro-abscessess in the
    epidermis
  • Langerhan cells and lymphocytes are also
    increased
  • Main abnormality is the increased epidermal cell
    turn over

11
Two hypothesis
  1. Hyperproliferation may be due to immunological
    response. Cytokines released by lymphocytes and
    langerhan cells may further stimulate the
    inflammatory cells which cause epidermal cell
    turn over at an increased rate

12
  • 2. Epithelial cells themselves produce cytokines
    which promote proliferation of epithelial cells
    and attract lymphocytes

13
  • DIAGNOSIS

14
DIAGNOSIS
  • A diagnosis of psoriasis is usually based on the
    appearance of the skin
  • There are no special blood tests or diagnostic
    procedures
  • Skin biopsy, may be needed to rule out other
    disorders and to confirm the diagnosis
  • Skin from a biopsy will show clubbed rete
    pegs, if positive for psoriasis
  • Another sign of psoriasis is that when the
    plaques are scraped, one can see pinpoint
    bleeding from the skin below 

15
  • Rete pegs are the epithelial extensions that
    project into the underlying connective tissue

16
  • CLINICAL FEATURES

17
CLINICAL FEATURES
  • Typical psoriatic lesion
  • is red, scaly, sharply
  • demarcated plaque

18
  • It can be on any
  • size and can affect
  • any part of the
  • body

19
  • The scales are silvery and easily scraped off
    revealing tiny bleed points
  • Psoriasis is not typically itchy, but it can
    cause itching when severely inflammed and rapidly
    spreading to the palms and soles

20
  • Different patterns of psoriasis are
  • Guttate psoriasis
  • Chronic plaque psoriasis
  • Psoriasis of scalp
  • Psoriasis of nails
  • Psoriasis of palms and soles
  • Flexural psoriasis
  • Erythrodermic and generalized pustular psoriasis
  • Psoriatic arthropathy

21
GUTTATE PSORIASIS
  • Multiple small plaques are seen all over the body
  • Mainly seen in children after streptococcal sore
    throat
  • Self limiting after a few weeks

22
CHRONIC PLAQUE PSORIASIS
  • Medium and large plaques occur on the limb and
    trunk
  • Very persistent

23
PSORIASIS OF THE SCALP
  • May occur as demarcated plaques or may involve
    the entire scalp extending to the hairline
  • Scales are white, thick and chalky
  • Hair loss will occur if the scalp is thickly
    scaled
  • Recover if the scales are cleared and kept under
    control

24
PSORIASIS OF THE NAILS
  • Pitting, onycholysis and hyperkeratosis under the
    nail
  • Very resistant

25
PSORIASIS OF THE PALMS AN SOLES
  • Sharp demarcation of the involved areas
  • Affected areas are inflammed and scaly and may
    contain sterile pustules of large pin head size.
    These pustules dry up and form brown macules
  • Affected skin becomes hyperatotic and fissuring
  • Secondary infection with itching and pain are
    common

26
FLEXURAL PSORIASIS
  • Psoriasis occurs in the axillae, submammary
    areas, groin and genitalia
  • Demarcation is present, but the affected areas
    are glazy rather than scaly and is bright red in
    color

27
ERYTHRODERMIC AND GENERALIZED PUSTULAR PSORIASIS
  • Severe and life threatening condition
  • Uncommon
  • Whole skin surface is involved and highly
    inflammed and the patient is sick
  • Pustules are sterile and coalesce to form sheets
    of pus

28
PSORIATIC ARTHROPATHY
  • Occurs in 5 of the patients with psoriasis
  • Similar to RA, but RF is negative
  • Different patterns
  • Distal Arthritis
  • Large Joint Involvement
  • Spodilitis/ Sacroiliitis

29
  • TREATMENT

30
TREATMENTAimed at controlling the
current attack and not curing, and does not
influence future progress of the disease
  • TOPICAL THERAPY
  • Emolients
  • Topical Steroids
  • Dithranol
  • Coal Tar
  • Salicylic Acid
  • Vitamin D Analogues
  • UVB
  • SYSTEMIC THERAPY
  • PUVA
  • Cytotoxic Drugs
  • Immunosuppressant Drugs
  • Acitretin
  • Photodynamic Therapy
  • Systemic Steroids

31
TOPICAL THERAPY
  • EMOLIENTS
  • Used alone in very mild cases
  • Used along with other therapies for moderate to
    severe disease

32
  • 2. TOPICAL STEROIDS
  • Most useful for acutely inflammed psoriasis
  • Mild steroids are used on face and flexures
  • Potent steroids are used on hands and feet in
    combination with Clioquinol or Salicylic acid
  • Aq. and alcoholic solutions cause stinging and
    burning, thus usually ointments, creams and
    mousse are prefered
  • Use of potent steroids on large areas of
    psoriasis may cause rebound flare when
    discontinued

33
  • 3. DITHRANOL
  • Burns the skin
  • Stains the skin, clothes and bath fittings
  • Unsuitable for use on face and flexures and
    acutely inflamed psoriasis
  • 2 regimens - Ingram regimen
  • - Short contact regimen

34
  • 4. COAL TAR
  • Used in combination with emolients, topical
    steroids, and salicylic acid
  • Used for guttate psoriasis, psoriasis of the
    scalp, and localized pustular psoriasis of the
    palms and soles
  • Efficiency of coal tar is enhanced when used with
    UVB

35
  • 5. SALICYLIC ACID
  • Useful to remove the scales
  • Used in preparation for other treatment

36
  • 6. VITAMIN D ANALOGUES
  • Efficacy of topical vit D analogues is enhanced
    when used in combination with topical steroids
    and UVB
  • Calciptriol Tacalcitol
  • Calciptriol is more effective than coal tar and
    dithranol. It cannot be used on face.
  • Tacalcitol is used for once daily treatment of
    chronic plaque psoriasis. It can be used on the
    face

37
  • 7. UVB
  • Short wavelength ultraviolet light is used in
    combination with coal tar or dithranol
  • Narrow band UVB is more effective

38
SYSTEMIC THERAPY
  • PUVA
  • Used for the treatment of moderate to severe
    chronic plaque psoriasis
  • PSORALENS drugs that are activated by UVA
    (320-400nm), to interfere with the DNA synthesis
    and reduce the epidermal cell turn over
  • Eg 5-methoxy psoralen 8-methoxy psoralen
  • Can be administered orally or it can be applied
    topically

39
  • The time of exposure is calculated based upon the
    previous light testing and the time interval is
    increased if tolerated by the patient as the
    treatment progresses
  • Treatment is given twice weekly for 6 weeks
  • Unless the disease is severe, maintenance dose is
    avoided to minimize the long term side effects
  • Adverse effects Nausea, pruritis, dry skin,
    aging of the skin, melanoma and non-melanoma skin
    cancer

40
  • 2. CYTOTOXIC DRUGS
  • Methotrexate hydroxycarbamide
  • METHOTREXATE
  • Most effective in the treatment of psoriatic
    arthritis
  • Test dose- 2.5 mg
  • Then 30 mg weekly
  • Side effects nausea, fatigue, GI bleeding

41
  • HYDROXYCARBAMIDE
  • It should be used continuously as relapse will
    occur when the drug is stopped
  • Causes bone marrow depression

42
  • 3. IMMUNOSUPPRESSANT DRUGS
  • CICLOSPORIN
  • Severe psoriasis
  • Dose is 2-5 mg/kg/day
  • Relapse may occur when the drug is stopped but
    intermittent therapy is preferred to maintenance
    therapy
  • Avoid sun over exposure, PUVA UVB therapy

43
  • 4. ACITRETIN
  • Used for severe resistant psoriasis, acute
    pustular psoriasis, and palmoplantar psoriasis
  • Has teratogenic effect
  • Re-PUVA therapy acitretin PUVA
  • It causes bone maturation abnormality, LFT and
    serum lipid levels
  • Causes dry skin and hair loss

44
  • 5. PHOTODYNAMIC THERAPY
  • 5-aminolaevullinic acid (ALA) causes local
    accumulation of proto porphyrin 9 which is
    activated by irradiation with visible light and
    causes tissue destruction
  • Used for localized plaque psoriasis
  • Causes burning sensation at the site of treatment

45
  • 6. SYSTEMIC STEROIDS
  • Not commonly used
  • May be used for the management of life
    threatening erythroderma
  • Systemic steroids or their withdrawal may itself
    provoke acute generalised pustular psoriasis

46
QUESTIONS???
47
THANK YOU
Write a Comment
User Comments (0)
About PowerShow.com